India, Nov. 6 -- US-based Veloxity Labs, abioanalytical CRO built for programmes that need speed with purpose, has announced the acquisition of the ZenoTOF 8600 system fromSciex, a global leader in life science analytical technologies.

Veloxity is the first bioanalytical CRO in the United States to acquire this new accurate mass spectrometer, with delivery expected later this year and installation/qualification starting January of 2026.

With this acquisition, Veloxity is expanding its toolkit for peptide and protein bioanalysis-strengthening method development speed, identity confirmation and interference resolution-while complementing its existing LC-MS/MS (triple quadrupole) platforms.

The ZenoTOF 8600 system investment is a key part...